Sharon Benzeno, Chief Commercial Ofc Imm Med: Adaptive Biotechnologies ADPT Planned sale · Filed 25/11/20

Trade details

Type: Planned sale notice
Stock: Adaptive Biotechnologies ADPT
Person: Sharon BenzenoChief Commercial Ofc Imm Med
Planned sale date: 25/11/20
Filed: 25/11/20

0.1% of shares outstanding to be sold

Adaptive Biotechnologies trades, last 26 weeks

What else happened in Adaptive Biotechnologies around then

Filed or reported within 30 days of the trade day · 25/10/21~25/12/20

Sharon Benzeno's recent trades

Sharon BenzenoChief Commercial Ofc Imm Med
Sell10b5-1 planAdaptive Biotechnologies
Sell10b5-1 plan
Adaptive Biotechnologies
ADPT
$3.3M
154,768 sh
$3.3M
Filed 06/30
Traded 06/29
Sharon BenzenoChief Commercial Ofc Imm Med
Sell10b5-1 planAdaptive Biotechnologies
Sell10b5-1 plan
Adaptive Biotechnologies
ADPT
$231.7K
11,034 sh
$231.7K
Filed 06/30
Traded 06/26
Sharon BenzenoChief Commercial Ofc Imm Med
Planned sale10b5-1 planAdaptive Biotechnologies
Planned sale10b5-1 plan
Adaptive Biotechnologies
ADPT
$3.2M
152,931 sh
$3.2M
Filed 06/29
Traded 06/29
Sharon BenzenoChief Commercial Ofc Imm Med
Planned sale10b5-1 planAdaptive Biotechnologies
Planned sale10b5-1 plan
Adaptive Biotechnologies
ADPT
$260.6K
12,871 sh
$260.6K
Filed 06/26
Traded 06/26
Sharon BenzenoChief Commercial Ofc Imm Med
Planned saleAdaptive Biotechnologies
Planned sale
Adaptive Biotechnologies
ADPT
$916.3K
63,103 sh
$916.3K
Filed 03/16
Traded 03/11